Temozolomide (TMZ) and cisplatin (CDDP) combination in naive patients with stage IV melanoma. Definitive results of a phase II multicenter trial

被引:0
|
作者
Tourani, J.
Wiersbicka, E.
Mourey, L.
Guillot, B.
Sassolas, B.
Bedane, C.
机构
[1] CHU Poitiers, Poitiers, France
[2] Inst Claudius Regaud, Toulouse, France
[3] CHU Montpellier, Hop St Eloi, Montpellier, France
[4] CHU Brest, Brest, France
[5] CHU Limoges, Limoges, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8572
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
    Gogas, H
    Polyzos, A
    Tsoutsos, D
    Panagiotou, P
    Iconomou, T
    Papadopoulos, S
    Papadopoulos, O
    Agarwala, S
    Stavrinidis, I
    Fountzilas, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 723S - 723S
  • [32] Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study
    Christos Christodoulou
    Dimitrios Bafaloukos
    Helen Linardou
    Gerassimos Aravantinos
    Aristotelis Bamias
    Maria Carina
    George Klouvas
    Dimosthenis Skarlos
    Journal of Neuro-Oncology, 2005, 71 : 61 - 65
  • [33] Final results of a phase II multicenter trial of HF10, a replication-competent HSV-1 oncolytic virus, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma.
    Andtbacka, Robert Hans Ingemar
    Ross, Merrick I.
    Agarwala, Sanjiv S.
    Taylor, Matthew H.
    Vetto, John T.
    Neves, Rogerio Izar
    Daud, Adil
    Khong, Hung T.
    Ungerleider, Richard S.
    Tanaka, Maki
    Grossmann, Kenneth F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Phase II trial of nemorubicin hydrocloride (nemorubicin) in combination with cisplatin (cDDP) in patients (pts) with hepatocellular carcinoma (HCC): First step results
    Izzo, F.
    Catino, A. M.
    Vogl, T. J.
    Middleton, M.
    Valle, J. W.
    Fiore, F.
    Gadaleta, C. D.
    Pirotta, R. M.
    Martignoni, M.
    Laffranchi, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] PHASE I STUDY OF THE COMBINATION OF DOCETAXEL, TEMOZOLOMIDE AND CISPLATIN IN PATIENTS WITH METASTATIC MELANOMA
    Kim, K. B.
    Hwu, W. J.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Camacho, L. H.
    Ng, C.
    Hernandez, I.
    Frost, A. M.
    Jack, M.
    Hwu, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 246 - 246
  • [36] Immunological results of a phase II randomized trial of multipeptide vaccines for melanoma.
    Slingluff, CL
    Petroni, G
    Bullock, KA
    Bissonnette, E
    Hibbitts, S
    Murphy, C
    Anderson, N
    Grosh, WW
    Neese, PY
    Fink, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 710S - 710S
  • [37] Phase II trial of neoadjuvant temozolomide in resectable melanoma patients
    Shah, G. D.
    Socci, N. D.
    Gold, J. S.
    Wolchok, J. D.
    Carvajal, R. D.
    Panageas, K. S.
    Viale, A.
    Brady, M. S.
    Coit, D. G.
    Chapman, P. B.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1718 - 1722
  • [38] Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma
    Kevin B. Kim
    Wen-Jen Hwu
    Nicholas E. Papadopoulos
    Agop Y. Bedikian
    Luis H. Camacho
    Chaan Ng
    Ingrid M. Hernandez
    Angela M. Frost
    Monica A. Jack
    Patrick Hwu
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 161 - 167
  • [39] Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma
    Kim, Kevin B.
    Hwu, Wen-Jen
    Papadopoulos, Nicholas E.
    Bedikian, Agop Y.
    Camacho, Luis H.
    Ng, Chaan
    Hernandez, Ingrid M.
    Frost, Angela M.
    Jack, Monica A.
    Hwu, Patrick
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 161 - 167
  • [40] Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma
    Ranson, Malcolm
    Hersey, Peter
    Thompson, Damien
    Beith, Jane
    McArthur, Grant A.
    Haydon, Andrew
    Davis, Ian D.
    Kefford, Richard F.
    Mortimer, Peter
    Harris, Peter A.
    Baka, Sofia
    Seebaran, Augustus
    Sabharwal, Ami
    Watson, Amanda J.
    Margison, Geoffrey P.
    Middleton, Mark R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2540 - 2545